-
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial
Ulas, E. B., Purcell, N. D., Houda, I., Hashemi, S. M. S., Veltman, J., Daniels, J. M. A., Fransen, M. F., Radonic, T., Beeloo, L. R., van Rossum, P. S. N., van Maldegem, F., Barlo, N., Disselhorst, M., van Laren, M., Tiemessen, M. A., Tarasevych, S., van Haarst, J. M., van Tilburg, P., Kunst, P. W. A. & Moons-Pasic, A. & 7 others, , 22 Jun 2026, In: Journal for Immunotherapy of Cancer. 14, 6Research output: Contribution to Journal › Article › Academic › peer-review
-
Pharmacy compounding for rare diseases: The story of CDCA
Bouwhuis, N., 2026, 123 p.Research output: PhD Thesis › PhD-Thesis - Research and graduation internal
-
Pharmacokinetic Cross-Over Study of Pharmacy-Compounded Chenodeoxycholic Acid Capsules Compared to Authorized Capsules
Bouwhuis, N., Jacobs, B. A. W., Majait, S., Vaz, F. M., Hollak, C. E. M., Swart, E. L. & Kemper, E. M., 1 Dec 2025, In: Pharmaceutics. 17, 12, 1525.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications